LYMPHOCYTE SUBSET TEST AS A DETERMINANT OF CYTOMEGALOVIRUS PROPHYLAXIS IN RENAL TRANSPLANT RECIPIENTS WITH ANTI-THYMOCYTE GLOBULIN INDUCTION THERAPY. Issue 3 (September 2020)